Cormorant Asset Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,837,739
Closed -$7.9M 45
2025
Q1
$7.9M Hold
1,837,739
0.59% 32
2024
Q4
$15.8M Buy
+1,837,739
New +$15.8M 0.87% 27